Pallister–Killian syndrome in the practice of a pediatrician and a neurologist
https://doi.org/10.46563/2686-8997-2025-6-1-113-119
EDN: yrjvnk
Abstract
Pallister–Killian syndrome (tetrasomy 12p, mosaic isochromosome 12p syndrome) (OMIM#601803) is a rare genetic disease characterized by multiple developmental abnormalities and mental retardation. The frequency of occurrence is 5.1:1,000,000. Newborns with this syndrome are characterized by muscular hypotension, which causes children to experience breathing difficulty and feeding problems, craniofacial dysmorphic disorder: a “rough” face — a high protruding forehead, oblique eye slits with epicanthus, hypertelorism, a wide and flattened nose with turned-out nostrils, low-set and dysplastic ears, micrognathia, a wide mouth with an inverted lower lip, a thin upper lip in the shape of a Cupid’s bow. Most children have a high hairline, bilateral frontal-temporal alopecia, sparse eyebrows or eyelashes, and areas of hypopigmentation in the form of light spots or streaks. The neurological status most often shows a serious delay in the pace of speech, motor, and intellectual development, although a more “mild” course of the disease is described. Specific speech disorders are also characteristic.
To verify the diagnosis, the child needs to examine the buccal epithelium or fibroblasts using FISH analysis. The prognosis of the disease is unfavourable. It is also aggravated by the presence of profound intellectual disability and the possible development of seizures. Currently, no specific treatment for patients has been developed. Depending on the clinical manifestations, therapy may include surgical correction of the identified congenital disorders. One of the important stages of managing patients with such a diagnosis is working with psychologists and educators to support the intellectual development and socialization of the child.
The article presents a clinical case of managing a child with Pallister–Killian syndrome, as well as current views on the diagnosis of this disease.
Contribution:
Kharitonova N.A. — concept and design of the study, collection and processing of material, writing the text, editing;
Basargina M.A. — editing;
Vavilova N.V. — collection and processing of material;
Uvakina Ye.V. — collection and processing of material;
Nesterovich M.I. — collection and processing of material.
All authors — responsibility for the integrity of all parts of the manuscript and approval of its final version.
Acknowledgment. The study had no sponsorship.
Conflict of interest. The authors declare no conflict of interest.
Received: January 20, 2025
Accepted: February 7, 2025
Published: August 20, 2025
About the Authors
Natalia A. KharitonovaRussian Federation
PhD (Medicine), senior researcher, neonatologist, pediatrician, Department of pathology of newborns and young children with somatic rehabilitation, National Medical Research Center for Children’s Health, Moscow, 119991, Russian Federation
e-mail: kharitonovan@nczd.ru
Milana A. Basargina
Russian Federation
PhD (Medicine), senior researcher, Head, Department of pathology of newborns and young children with somatic rehabilitation, National Medical Research Center for Children’s Health, Moscow, 119991, Russian Federation
Natalya V. Vavilova
Russian Federation
Neurologist, Department of pathology of newborns and young children with somatic rehabilitation, National Medical Research Center for Children’s Health, Moscow, 119991, Russian Federation
Evgenia V. Uvakina
Russian Federation
PhD (Medicine), neurologist, senior researcher, Center of Child Psychoneurology, National Medical Research Center for Children’s Health, Moscow, 119991, Russian Federation
e-mail: uvakina.ev@nczd.ru
Marina I. Nesterovich
Russian Federation
Neonatologist, junior researcher, Department of pathology of newborns and young children with somatic rehabilitation, National Medical Research Center for Children’s Health, Moscow, 119991, Russian Federation
References
1. Sudovskaya T.V., Kokoeva N.Sh., Bobrovskaya Yu.A., Makarova A.A. The clinical cases of Pallister–Killians’s syndrome in a child. Rossiiskaya pediatricheskaya oftal’mologiya. 2017; 12(3): 163–5. https://doi.org/10.18821/1993-1859-2017-12-3-163-165 https://elibrary.ru/zgzevd (in Russian)
2. NORD – National Organization for Rare Disorders. Vogel I. Pallister Killian Mosaic Syndrome; 2016. Available at: https://rarediseases.org/rare-diseases/pallister-killian-mosaic-syndrome/
3. Wu X., Xie X., Su L., Lin N., Liang B., Guo N., et al. Prenatal diagnosis of Pallister–Killian syndrome and literature review. J. Cell. Mol. Med. 2021; 25(18): 8929–35. https://doi.org/10.1111/jcmm.16853
4. Blyth M., Maloney V., Beal S., Collinson M., Huang S., Crolla J., et al. Pallister–Killian syndrome: a study of 22 British patients. J. Med. Genet. 2015; 52(7): 454–64. https://doi.org/10.1136/jmedgenet-2014-102877
5. Ryzhkova A.I., Serebryakova E.N., Soldatkina O.I., Zemtsova L.V., Gunbina I.V. Family case of marker chromosome detection. Pediatricheskii vestnik Yuzhnogo Urala. 2018; (1): 82–6. (in Russian)
6. Karamysheva T.V., Gayner T.A., Zakirova E.G., Rubtsov N.B. New sight on assessment of clinical value of human supernumerary marker chromosomes. Genetics. 2020; 56(5): 514–24. https://doi.org/10.1134/S1022795420040031 https://elibrary.ru/vimexb
7. Zolotukhina T.V., Schilova N.V., Minzhenkova M.E., Kozlova O.Ju., Tsvetkova T.G., Markova Zh.G., et al. FISH analysis for identification and specification of complicated cases of chromosomal aberrations. Meditsinskaya genetika. 2011; 10(11): 3–8. https://elibrary.ru/tjxgbl (in Russian)
8. Vogel I., Lyngbye T., Nielsen A., Pedersen S., Hertz J.M. Pallister–Killian syndrome in a girl with mild developmental delay and mosaicism for hexasomy 12p. Am. J. Med. Genet. 2009; 149A(3): 510–4. https://doi.org/10.1002/ajmg.a.32681
9. Sailer S., Díaz G.A., García M.H., Díaz A.S., Miguélez J.M.R., Fernández M.E.M. Pallister–Killian syndrome: the diagnosis is in the detail. Klin. Padiatr. 2019; 231(2): 93–5. https://doi.org/10.1055/a-0781-2564
10. Salzano E., Raible S.E., Krantz I.D. Рallister-Кillian syndrome. In: Carey J.C., Battaglia A., Viskochil D., Cassidy S.B. Cassidy and Allanson’s Management of Genetic Syndromes. John Wiley & Sons; 2020: 717–33. https://doi.org/10.1002/9781119432692.ch45
11. Karaman B., Kayserili H., Ghanbari A., Uyguner Z.O., Toksoy G., Altunoglu U., et al. Pallister–Killian syndrome: clinical, cytogenetic and molecular findings in 15 cases. Mol. Cytogenet. 2018; 11: 45. https://doi.org/10.1186/s13039-018-0395-z
12. Alqahtani A.S., Putoux A., Bonnet Dupeyron M.N., Carneiro M., Lion–Francois L., Rossi M., et al. Postnatal clinical phenotype of five patients with Pallister–Killian Syndrome (tetrasomy 12p): Interest of array CGH for diagnosis and review of the literature. Mol. Genet. Genomic Med. 2019; 7(10): e00939. https://doi.org/10.1002/mgg3.939
13. Samango-Sprouse C.A., Hamzik M.P., Rosenbaum K., Khaksari K., Mitchell F., Kommareddi R., et al. Case report: a case study on the neurodevelopmental profile of a child with Pallister–Killian syndrome and his unaffected twin. Front. Pediatr. 2022; 10: 817133. https://doi.org/10.3389/fped.2022.817133
14. Shriberg L.D., Strand E.A., Jakielski K.J., Mabie H.L. Estimates of the prevalence of speech and motor speech disorders in persons with complex neurodevelopmental disorders. Clin. Linguist. Phonet. 2019; 33(8): 707–36. https://doi.org/10.1080/02699206.2019.1595732
15. Kostanecka C., Close L.B., Izumi K., Krantz I.D., Pipan M. Developmental and behavioral characteristics of individuals with Pallister–Killian syndrome. Am. J. Med. Genet. A. 2012; 158A(12): 3018–25. https://doi.org/10.1002/ajmg.a.35670
16. Barkovich E.J., Lateef T.M., Whitehead M.T. Neuroimaging findings in Pallister–Killian syndrome. Neuroradiol. J. 2018; 31(4): 403–11. https://doi.org/10.1177/1971400917744798
17. Wilkens A., Liu H., Park K., Campbell L.B., Jackson M., Kostanecka A., et al. Novel clinical manifestations in Pallister–Killian syndrome: comprehensive evaluation of 59 affected individuals and review of previously reported cases. Am. J. Med. Genet. A. 2012; 158A(12): 3002–17. https://doi.org/10.1002/ajmg.a.35722
18. Yalcin A., Ceylan M., Bayraktutan O.F., Sonkaya A.R., Yuce I. Age and gender related prevalence of intracranial calcifications in CT imaging; data from 12,000 healthy subjects. J. Chem. Neuroanat. 2016; 78: 20–4. https://doi.org/10.1016/j.jchemneu.2016.07.008
19. Yatsyk L.M., Karkashadze G.A., Altunin V.V., Povalyaeva I.A., Prudnikov P.A., Vishneva E.A., et al. Functional near-infrared spectroscopy as promising method for studying cognitive functions in children. Voprosy sovremennoi pediatrii. 2022; 21(6): 479–86. https://doi.org/10.15690/vsp.v21i6.2490 https://elibrary.ru/zpwxid (in Russian)
20. Thakur S., Gupta R., Tiwari B., Singh N., Saxena K.K. Pallister–Killian syndrome: Review of fetal phenotype. Clin. Genet. 2019; 95(1): 79–84. https://doi.org/10.1111/cge.13381
21. Chau M.H.K., Lam D.Y.M., Zhu X., Kwok Y.K.Y., Ting Y.H., Chan W.P., et al. The utility of genome-wide cell-free DNA screening in the prenatal diagnosis of Pallister–Killian syndrome. Prenat. Diagn. 2020; 40(8): 1005–12. https://doi.org/10.1002/pd.5721
22. Costa L.S., Zandona-Teixeira A.C., Montenegro M.M., Dias A.T., Dutra R.L., Honjo R.S., et al. Cytogenomic delineation and clinical follow-up of 10 Brazilian patients with Pallister–Killian syndrome. Mol. Cytogenet. 2015; 8: 43. https://doi.org/10.1186/s13039-015-0142-7
Review
For citations:
Kharitonova N.A., Basargina M.A., Vavilova N.V., Uvakina E.V., Nesterovich M.I. Pallister–Killian syndrome in the practice of a pediatrician and a neurologist. L.O. Badalyan Neurological Journal. 2025;6(2):113-119. (In Russ.) https://doi.org/10.46563/2686-8997-2025-6-1-113-119. EDN: yrjvnk